4XZ-77343-46817
3 vaccinations
2 coded responses
33 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 530 / WI
- Registered
- 2021-06-19
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Registered dependents
UUQ-14706-51119
Child or adolescent in my care · Male · 2022-01-14
Timeline
-
2021-06-19
Registered in v-safe
-
2021-06-19
Dose 1 — Pfizer-BioNTech
- 2021-06-19
-
2021-06-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-06-21
- 2021-06-23
- 2021-06-24
- 2021-06-25
- 2021-06-26
- 2021-07-05
-
2021-07-10
Dose 2 — Pfizer-BioNTech
-
2021-07-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, DiarrheaAdult check-in
-
2021-07-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-07-13
- 2021-07-14
- 2021-07-15
- 2021-07-16
- 2021-07-17
- 2021-07-24
- 2021-07-31
-
2021-08-07
Survey response — day 28, dose 2MedDRA: Pre-eclampsia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Diagnosed with preeclampsiaMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-07
Report sent to call center — day 28, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-10
- 2021-08-14
- 2021-08-21
- 2021-10-14
-
2022-01-11
Survey response — 6 months, dose 2MedDRA: Oropharyngeal pain, Paranasal sinus discomfort — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Sore throat, sinus pressureMedDRA releases: 2024-11 · check-in free text available
-
2022-01-13
Dose 3 — Pfizer-BioNTech
-
2022-01-14
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Itching · Fatigue or tirednessAdult check-in
-
2022-01-15
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-01-16
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-01-17
-
2022-01-18
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-01-22
- 2022-01-27
- 2022-02-03
- 2022-02-10
- 2022-02-18
- 2022-02-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-19 | Pfizer-BioNTech | No |
| 2 | 2021-07-10 | Pfizer-BioNTech | No |
| 3 | 2022-01-13 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-08-07 | Unsuccessful |
Free text
Release 9 — day 28, dose 2
Symptoms: Diagnosed with preeclampsia
Release 10 — 6 months, dose 2
Symptoms: Sore throat, sinus pressure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Pre-eclampsia | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release